|
|
|
|
|
Intuitive Surgical Inc (ISRG) |
|
|
|
| |
Intuitive Surgical Inc 's Yearly Operating Income Growth 5 Years |
| |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
Annual Operating Income Annual Growth Rates Y/Y▼
|
ISRG Annual Operating Income Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
| Y / Y Annual Operating Income Change |
12.03 % |
-13.39 % |
73.46 % |
-23.62 % |
14.6 % |
| Annual Operating Income (in millions $) |
$1,766.80 |
$1,577.10 |
$1,821.00 |
$1,049.80 |
$1,374.50 |
| Annual Operating Income Growth
Comment |
Intuitive Surgical Inc 's Annual Operating Income for the fiscal year ended 2023, grew by 12.03% to $1,766.80 millions, from $1,577.10 millions achieved a year ago. Intuitive Surgical Inc 's growrh rate for Operating Income improved from -13.39 % decline in the fiscal year 2022.
Intuitive Surgical Inc Annual Income Statement
|
|
You need to upgrade your Flash Player
|
| Companies with similar 2023 Annual Operating Income within Healthcare Sector | Y/Y Operating Income Growth % | 2023 Annual Operating Income | | Pfizer Inc |  -98.84 % | $ 416.000 millions | | Abbvie Inc | -29.59 % | $ 12,757.000 millions | | Sanofi | -26.09 % | $ 8,820.000 millions | | Amgen Inc | -17.45 % | $ 7,897.000 millions | | Moderna Inc |  0.00 % | $ -4,239.000 millions | | Novartis Ag |  6.22 % | $ 9,769.000 millions | | Abbott Laboratories | -22.53 % | $ 6,478.000 millions | | Bristol myers Squibb Company | -12.15 % | $ 7,282.000 millions | | Gilead Sciences Inc | 3.75 % | $ 7,605.000 millions | | Eli Lilly And Company | 43.92 % | $ 10,257.700 millions | | 3m Company | 0.00 % | $ -9,128.000 millions | | Medtronic Plc | -4.64 % | $ 5,485.000 millions | | Regeneron Pharmaceuticals Inc | -14.58 % | $ 4,047.100 millions | | Vertex Pharmaceuticals Inc | -11.03 % | $ 3,832.000 millions | | Astrazeneca Plc | 118.07 % | $ 8,193.000 millions | | Stryker Corp | 36.85 % | $ 3,888.000 millions | | Hologic Inc | -59.27 % | $ 668.400 millions | | Viatris Inc | -52.54 % | $ 766.200 millions | | Avantor Inc | -38.41 % | $ 696.400 millions | | Vir Biotechnology Inc | 0.00 % | $ -684.305 millions | | Henry Schein Inc | -17.67 % | $ 615.000 millions | | Revvity Inc | -59.57 % | $ 300.562 millions | | West Pharmaceutical Services Inc | -7.90 % | $ 676.000 millions | | Charles River Laboratories International inc | -5.08 % | $ 617.261 millions | | Align Technology inc | 0.16 % | $ 643.338 millions | | Incyte Corporation | 7.08 % | $ 620.525 millions | | Qiagen N v | -22.98 % | $ 409.938 millions | | The Cooper Companies Inc | 5.13 % | $ 533.100 millions | | Teleflex Incorporated | 1.40 % | $ 506.313 millions | | Bio rad Laboratories Inc | -30.08 % | $ 337.796 millions | | Select Medical Holdings Corp | 37.47 % | $ 554.874 millions | | Dexcom Inc | 52.69 % | $ 597.700 millions | | Dr Reddy s Laboratories Limited | 78.66 % | $ 695.000 millions | | Surgery Partners Inc | -4.93 % | $ 328.000 millions | | Chemed Corporation | -0.87 % | $ 340.569 millions | | Embecta Corp | -28.48 % | $ 221.500 millions | | Ensign Group Inc | -13.85 % | $ 255.367 millions | | Bio techne Corp | 0.68 % | $ 298.944 millions | | Medpace Holdings Inc | 20.86 % | $ 336.825 millions | | Halozyme Therapeutics Inc | 26.22 % | $ 337.574 millions | | Neurocrine Biosciences Inc | 0.40 % | $ 250.900 millions | | Sotera Health Company | 11.29 % | $ 276.692 millions | | Option Care Health Inc | 30.83 % | $ 314.595 millions | | Msa Safety Inc | -3.35 % | $ 231.320 millions | | Abcellera Biologics Inc | 0.00 % | $ -237.207 millions | | Elanco Animal Health Inc | 0.00 % | $ -843.000 millions | | Inmode Ltd | -1.02 % | $ 195.660 millions | | Adapthealth Corp | 0.00 % | $ -598.401 millions | | Patterson Companies Inc | 75.16 % | $ 275.971 millions | | Harmony Biosciences Holdings inc | 60.00 % | $ 192.030 millions | | Amphastar Pharmaceuticals Inc | 83.18 % | $ 196.987 millions | | Assertio Holdings inc | 0.00 % | $ -243.536 millions | | Insulet Corporation | 494.59 % | $ 220.000 millions | | Lantheus Holdings Inc | 911.11 % | $ 364.642 millions | | Takeda Pharmaceutical Company Limited | 0.00 % | $ 3,398.214 millions | | Biontech Se | 0.00 % | $ 773.248 millions |
Other Companies within Healthcare Sector and their 2023 Operating Income |
Y/Y Annual Operating Income Growth % |
2023 Operating Income | | Integra Lifesciences Holdings Corp | -53.36 % | $ 111.526 millions | | Globus Medical Inc | -41.41 % | $ 133.142 millions | | Masimo Corp | -35.24 % | $ 136.500 millions | | Bausch and Lomb Corp | -37.20 % | $ 130.000 millions | | Exelixis Inc | -15.42 % | $ 170.885 millions | | Amedisys Inc | -13.33 % | $ 156.394 millions | | Biomarin Pharmaceutical Inc | 6.04 % | $ 158.097 millions | | Owens and Minor inc | -26.76 % | $ 104.508 millions | | Sonida Senior Living Inc | 11.43 % | $ 156.172 millions | | Zymeworks Inc | -206.15 % | $ -138.053 millions | | Shockwave Medical Inc | 28.23 % | $ 159.093 millions | | Integer Holdings Corporation | 38.02 % | $ 167.330 millions | | Molecular Partners Ag | -152.59 % | $ -61.108 millions | | Corcept Therapeutics Inc | -4.46 % | $ 107.282 millions | | Catalyst Pharmaceuticals Inc | -14.85 % | $ 86.812 millions | | Mesoblast Ltd | -26.00 % | $ 74.776 millions | | Molecular Templates Inc | -88.64 % | $ 10.466 millions | | Merit Medical Systems Inc | 41.38 % | $ 123.944 millions | | Haemonetics Corporation | 95.00 % | $ 156.033 millions | | Phibro Animal Health Corporation | -8.97 % | $ 71.847 millions | | Perrigo Company Plc | 93.59 % | $ 151.900 millions | | Avanos Medical Inc | -94.59 % | $ 4.200 millions | | Conmed Corporation | 71.43 % | $ 120.603 millions | | Taro Pharmaceutical Industries Ltd | -73.02 % | $ 17.714 millions | | National Vision Holdings Inc | -175.41 % | $ -46.826 millions | | Healthcare Services Group Inc | -39.66 % | $ 35.036 millions | | Neogen Corporation | -36.21 % | $ 37.515 millions | | Dariohealth Corp | 0.00 % | $ 56.189 millions | | Ufp Technologies Inc | 3.64 % | $ 57.664 millions | | Universe Pharmaceuticals Inc | -105.88 % | $ -3.527 millions | | Intercure Ltd | -182.00 % | $ -41.567 millions | | National Research Corporation | -13.04 % | $ 40.045 millions |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
